Tectonic Therapeutic Inc.
Organization details
- Legal name
- Tectonic Therapeutic Inc.
- Former names
- AvroBio, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- New York
- Headquarters city
- Watertown
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TECX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001681087
- EIN
- 81-0710585
Board of directors
-
Alise Reicin · Director · Chief Executive OfficerSince 2024
-
Annalisa Jenkins · DirectorSince 2023
-
Bruce Booth · DirectorSince 2023
-
Christopher Paige · DirectorSince 2023
-
Francois Nader · DirectorSince 2026
-
Gail M. Farfel · DirectorSince 2023
-
Geoffrey Mackay · Director · President & CEOSince 2023
- Since 2023
-
Jessica Caroline Chutter · DirectorSince 2026
-
Philip J. Vickers · DirectorSince 2023
-
Phillip B. Donenberg · DirectorSince 2023
-
Praveen P. Tipirneni · DirectorSince 2024
-
Stefan Vitorovic · DirectorSince 2024
- Since 2024
-
Timothy A. Springer · DirectorSince 2024
Chief executives
Director election results
Annual meeting of June 8, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
79.5%
-
96.6%
Board connections
12 of this board's directors also sit on 27 other boards. 25 are in the same sector.
-
Akebia Therapeutics Inc. Same sectorvia Philip J. Vickers
-
Alector Inc. Same sectorvia Terrance Mcguire
-
BioMarin Pharmaceutical Inc. Same sectorvia Ian T. Clark
-
BridgeBio Oncology Therapeutics Inc. Same sectorvia Praveen P. Tipirneni
-
COMPASS Pathways Plc Same sectorvia Annalisa Jenkins
-
Cartesian Therapeutics Inc. Same sectorvia Timothy A. Springer
-
Corvus Pharmaceuticals Inc. Same sectorvia Ian T. Clark
-
Faeth Therapeutics Inc. Same sectorvia Phillip B. Donenberg
- via Ian T. Clark
-
Guardant Health Inc. Same sectorvia Ian T. Clark
-
Immatics N.V. Same sectorvia Alise Reicin
-
Invivyd Inc. Same sectorvia Terrance Mcguire
-
Korsana Biosciences Inc. Same sectorvia Terrance Mcguire
-
Kymera Therapeutics Inc. Same sectorvia Bruce Booth
-
Kyverna Therapeutics Inc. Same sectorvia Ian T. Clark
-
Mereo BioPharma Group plc Same sectorvia Annalisa Jenkins
-
Moderna Inc. Same sectorvia Francois Nader
-
Olema Pharmaceuticals Inc. Same sectorvia Ian T. Clark
-
PTC Therapeutics Inc. Same sectorvia Jessica Caroline Chutter
-
ProMIS Neurosciences Inc. Same sectorvia Gail M. Farfel
-
Q32 Bio Inc. Same sectorvia Alise Reicin
-
Sana Biotechnology Inc. Same sectorvia Alise Reicin
- via Terrance Mcguire
-
Sionna Therapeutics Inc. Same sectorvia Bruce Booth
-
Skye Bioscience Inc. Same sectorvia Annalisa Jenkins
-
Takeda Pharmaceutical Company Limited Same sectorvia Ian T. Clark
-
Taysha Gene Therapies Inc. Same sectorvia Phillip B. Donenberg
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $182,410
- 2 purchases by 2 insiders
- Sold, last 12 months
- $651,007
- 11 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 26, 2026 | Alise Reicin Director, Officer (Chief Executive Officer) | Option exercise | +10,000 | $2.38 | $23,800 |
| Sep 30, 2026 | McNamara Peter Officer (Chief Scientific Officer) | Open-market sale | −536 | $23.04 | $12,349 |
| Sep 25, 2026 | Lochner Daniel Officer (Chief Financial Officer) | Shares withheld for tax | −520 | $23.67 | $12,308 |
| Sep 25, 2026 | McNamara Peter Officer (Chief Scientific Officer) | Shares withheld for tax | −444 | $23.67 | $10,509 |
| Sep 25, 2026 | Alise Reicin Director, Officer (Chief Executive Officer) | Shares withheld for tax | −1,545 | $23.67 | $36,570 |
| Sep 25, 2026 | Marcella K. Ruddy Officer (Chief Medical Officer) | Shares withheld for tax | −525 | $23.67 | $12,427 |
| Sep 25, 2026 | Schwabish Marc Officer (Chief Business Officer) | Shares withheld for tax | −411 | $23.67 | $9,728 |
| Aug 25, 2026 | McNamara Peter Officer (Chief Scientific Officer) | Option exercise | +43 | $14.71 | $633 |
| Aug 25, 2026 | McNamara Peter Officer (Chief Scientific Officer) | Open-market sale | −43 | $36.52 | $1,570 |
| Aug 12, 2026 | McNamara Peter Officer (Chief Scientific Officer) | Option exercise | +43 | $14.71 | $633 |
| Aug 12, 2026 | McNamara Peter Officer (Chief Scientific Officer) | Open-market sale | −43 | $35.00 | $1,505 |
| Jun 30, 2026 | McNamara Peter Officer (Chief Scientific Officer) | Option exercise | +172 | $14.71 | $2,530 |
| Jun 30, 2026 | McNamara Peter Officer (Chief Scientific Officer) | Open-market sale | −172 | $35.00 | $6,020 |
| Jun 20, 2026 | Alise Reicin Director, Officer (Chief Executive Officer) | Shares withheld for tax | −924 | $30.34 | $28,034 |
| May 4, 2026 | Marcella K. Ruddy Officer (Chief Medical Officer) | Open-market sale | −1,065 | $30.00 | $31,950 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Tectonic Therapeutic Inc.
Who is the CEO of Tectonic Therapeutic Inc.?
Alise Reicin has been Tectonic Therapeutic Inc.'s Chief Executive Officer since June 2024.
How many directors are on Tectonic Therapeutic Inc.'s board?
Tectonic Therapeutic Inc.'s board has 15 directors: Alise Reicin, Annalisa Jenkins, Bruce Booth, Christopher Paige, Francois Nader, Gail M. Farfel, Geoffrey Mackay, Ian T. Clark, Jessica Caroline Chutter, Philip J. Vickers and 5 others.
Are Tectonic Therapeutic Inc. insiders buying or selling shares?
Over the last 12 months, Tectonic Therapeutic Inc. insiders bought $182,410 of shares in 2 purchases and sold $651,007 of shares in 11 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="tectonic-therapeutic-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.